The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. Content within the patient forum is user-generated and has not been reviewed by medical professionals. Other sections of the Melanoma Research Foundation website include information that has been reviewed by medical professionals as appropriate. All medical decisions should be made in consultation with your doctor or other qualified medical professional.

Insurance approved Nivo at stage 3!

Forums General Melanoma Community Insurance approved Nivo at stage 3!

  • Post
    Andrea in Nashville
    Participant

      Hi guys,

      First time posting but I've been lurking since I was diagnosed in April. Just wanted to share some good news. I was slated to start Ipi on Friday. My oncologist saw the press release about the ipi/nivo adjuvant study and asked my insurance if they would cover the nivo, and they said YES! I can't beleive it and I hope this can help some of you stay away from ipi if possible. 

    Viewing 0 reply threads
    • Replies
        AZSoCal
        Participant

          Interesting. Wonder if they would have allowed you to get Nivo by itself, assuming you had a negative reaction to the combo. Good luck!!

      Viewing 0 reply threads
      • You must be logged in to reply to this topic.
      About the MRF Patient Forum

      The MRF Patient Forum is the oldest and largest online community of people affected by melanoma. It is designed to provide peer support and information to caregivers, patients, family and friends. There is no better place to discuss different parts of your journey with this cancer and find the friends and support resources to make that journey more bearable.

      The information on the forum is open and accessible to everyone. To add a new topic or to post a reply, you must be a registered user. Please note that you will be able to post both topics and replies anonymously even though you are logged in. All posts must abide by MRF posting policies.

      Popular Topics